HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers

Emerging toxicities and management strategies (ID 3)

Lecture Time
17:25 - 17:45
Session Name
HER2 and beyond: The role for antibody drug conjugates (ADCs) in HER2 non overexpressing breast cancers
Room
Berlin Hall
Date
Thu, 11.05.2023
Time
16:45 - 18:15
Speakers
  • Sung-Bae Kim (Seoul, Korea, Republic of)
Authors
  • Sung-Bae Kim (Seoul, Korea, Republic of)